Latest: FDA Approves New Biosimilar for Oncology Treatment

Operational Challenges and Collaborative Solutions in Cell and Gene Therapy Implementation at UC Davis Health: Jenny Craven, PharmD, BCPS

Health systems must prepare for the growing impact of cell and gene therapies by addressing their high costs, complex care pathways, and payer collaboration needs to ensure timely and sustainable patient access.
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago